Sutro Biopharma, Inc.

STRONASDAQUSD
21.43 USD
0.01 (0.05%)AT CLOSE (11:59 AM EDT)
21.39
0.04 (0.19%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
21.39
0.04 (0.19%)
🔴Market: CLOSED

Sutro Biopharma, Inc. (STRO) trades at $21.44 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (174.8%) and a bullish Golden Cross on the moving averages. Furthermore, STRO is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Aug 26, 2026.

Open?$21.25
High?$21.83
Low?$20.97
Prev. Close?$21.44
Volume?214.9K
Avg. Volume?292.5K
VWAP?$21.39
Rel. Volume?0.73x
Bid / Ask
Bid?$15.00 × 600
Ask?$30.92 × 300
Spread?$15.92
Midpoint?$22.96
Valuation & Ratios
Market Cap?355.3M
Shares Out?16.6M
Float?15.0M
Float %?90.5%
P/E Ratio?N/A
P/B Ratio?-3.44
EPS?-$10.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Employees
128
Market Cap
355.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2018-09-27
Address
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-392-8412
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
50
Short Sent.?
35
Piotroski F-Score?1/9Weak
Altman Z-Score?-8.36Distress
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.37%High
Short Interest?1.9M
Days to Cover?5.4
Free Float15.0M
Avg Daily Volume344.6K
Settlement Date2026-08-14
Financial Health
Current Ratio?3.32Strong
Quick Ratio?3.32Strong
Cash Ratio?1.03Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-3.44CHEAP
P/S?
Peers
100
S&P
14
7.78HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.4CHEAP
EV/Sales?
Peers
100
S&P
23
6.59HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
174.8%STRONG
ROA?
S&P
3
-92.9%WEAK
Cash Flow & Enterprise
FCF?$-145619000
Enterprise Value?$301.0M
Fundamentals ratios updated end of day